Cargos activos de Chulho Park
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Oncotelic, Inc.
 Oncotelic, Inc. BiotechnologyHealth Technology Oncotelic, Inc. develops a therapeutic platform for cancer treatments. It conducts registration trials for multiple cancer indications including pancreatic, melanoma, and glioblastoma. The company was founded by Vuong Trieu and Chulho Park and is headquartered in Agoura Hills, CA. | Director Técnico/Científico/I+D | 01/01/2015 | - |
| Fundador | 01/01/2015 | - |
Historial de carrera de Chulho Park
Antiguos cargos conocidos de Chulho Park.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ONCOTELIC THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 22/04/2019 | 01/07/2021 |
| Mabprex, Inc. | Director Ejecutivo | 01/01/2010 | 01/01/2018 |
| Fundador | 01/01/2010 | 01/01/2018 | |
IgDraSol, Inc.
 IgDraSol, Inc. Pharmaceuticals: MajorHealth Technology Part of Cambridge Equities LP, IgDraSol, Inc. is a company that manufactures cancer therapeutics. The company is based in Fountain Valley, CA. The company was founded by Larn Hwang, Vuong Trieu. IgDraSol was acquired by NantPharma LLC from Sorrento Therapeutics, Inc. on May 15, 2015 for $1,290 million. | Corporate Officer/Principal | 01/01/2013 | 01/09/2013 |
Estadísticas
Internacional
| Estados Unidos | 5 |
Operativa
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 2 |
| Corporate Officer/Principal | 1 |
Sectorial
| Health Technology | 4 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ONCOTELIC THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 3 |
|---|---|
Oncotelic, Inc.
Oncotelic, Inc. BiotechnologyHealth Technology Oncotelic, Inc. develops a therapeutic platform for cancer treatments. It conducts registration trials for multiple cancer indications including pancreatic, melanoma, and glioblastoma. The company was founded by Vuong Trieu and Chulho Park and is headquartered in Agoura Hills, CA. | Health Technology |
IgDraSol, Inc.
IgDraSol, Inc. Pharmaceuticals: MajorHealth Technology Part of Cambridge Equities LP, IgDraSol, Inc. is a company that manufactures cancer therapeutics. The company is based in Fountain Valley, CA. The company was founded by Larn Hwang, Vuong Trieu. IgDraSol was acquired by NantPharma LLC from Sorrento Therapeutics, Inc. on May 15, 2015 for $1,290 million. | Health Technology |
| Mabprex, Inc. |
- Bolsa de valores
- Insiders
- Chulho Park
- Experiencia
